Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Jun-23 8:23 PM View:  | Ra Capital Management, LLC | Satsuma Pharmaceuticals, Inc. (STSA) | 08-Jun-23 | Disposition (change in control) | 5,914,250 | -- | -- | (100%) 5.91M to 0 | |
| 08-Jun-23 4:24 PM View: | Shin Nippon Biomedical Labo... 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 08-Jun-23 | Purchase | 8,423,730 | $0.91 | $7,665,600.00 | 34% 24.85M to 33.27M | |
| 08-Jun-23 4:24 PM View: | Shin Nippon Biomedical Labo... 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 06-Jun-23 | Private Purchase | 22,053,600 | $0.91 | $20,068,800.00 | 789% 2.79M to 24.85M | |
| 08-Jun-23 4:45 PM View: | Shah Rajeev M. Director 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 06-Jun-23 | Disposition (change in control) | 5,914,250 | $0.91 | $5,381,970.00 | (100%) 5.91M to 0 | |
| 08-Jun-23 4:48 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 06-Jun-23 | Disposition (change in control) | 13,877 | $0.91 | $12,628.10 | (100%) 13.88K to 0 | |
| 08-Jun-23 4:31 PM View: | Kollins John A President and CEO Director | Satsuma Pharmaceuticals, Inc. (STSA) | 06-Jun-23 | Disposition (change in control) | 305,911 | $0.91 | $278,379.00 | (100%) 305.91K to 0 | |
| 08-Jun-23 4:44 PM View: | Takanashi Ken Director 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 06-Jun-23 | Private Purchase Duplicate | 22,053,600 | $0.91 | $20,068,800.00 | 789% 2.79M to 24.85M | |
| 23-Nov-22 9:38 AM View: | Leonard Braden Michael 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 21-Nov-22 | Private Purchase | 150,000 | $0.71 | $106,740.00 | 2% 6.44M to 6.59M | |
| 16-Nov-22 4:32 PM View: | Leonard Braden Michael 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 15-Nov-22 | Purchase | 831,694 | $0.63 | $525,663.00 | 15% 5.61M to 6.44M | |
| 16-Nov-22 4:32 PM View: | Leonard Braden Michael 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 14-Nov-22 | Private Purchase | 5,608,310 | $0.69 | $3,868,610.00 | 100% 0 to 5.61M | |
| 16-Nov-22 4:05 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 14-Nov-22 | Sale | 3,250,000 | $0.71 | $2,294,500.00 | (88%) 3.71M to 461.29K | |
| 29-Nov-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 24-Nov-21 | Market Purchase | 2,922 | $5.42 | $15,837.20 | < 1% 3.71M to 3.71M | (3%) |
| 23-Nov-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 22-Nov-21 | Market Purchase | 9,979 | $5.49 | $54,784.70 | < 1% 3.7M to 3.71M | < 1% |
| 23-Nov-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 19-Nov-21 | Market Purchase | 3,225 | $5.44 | $17,544.00 | < 1% 3.7M to 3.7M | 2% |
| 12-Nov-21 4:31 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 11-Nov-21 | Market Purchase | 7,941 | $6.05 | $48,043.10 | < 1% 3.69M to 3.7M | 1% |
| 12-Nov-21 4:31 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 10-Nov-21 | Market Purchase | 9,622 | $5.85 | $56,288.70 | < 1% 3.68M to 3.69M | 5% |
| 10-Nov-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 08-Nov-21 | Market Purchase | 560 | $5.99 | $3,354.40 | < 1% 3.68M to 3.68M | 4% |
| 08-Nov-21 4:33 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 05-Nov-21 | Market Purchase | 7,800 | $5.95 | $46,410.00 | < 1% 3.67M to 3.68M | 2% |
| 08-Nov-21 4:33 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 04-Nov-21 | Market Purchase | 1,400 | $5.88 | $8,232.00 | < 1% 3.67M to 3.67M | 3% |
| 04-Nov-21 4:31 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 02-Nov-21 | Market Purchase | 8,880 | $5.64 | $50,083.20 | < 1% 3.66M to 3.67M | 8% |
| 02-Nov-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 29-Oct-21 | Market Purchase | 44,651 | $5.71 | $254,957.00 | 1% 3.61M to 3.66M | 6% |
| 29-Oct-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 28-Oct-21 | Market Purchase | 15,082 | $5.55 | $83,705.10 | < 1% 3.6M to 3.61M | < 1% |
| 29-Oct-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 27-Oct-21 | Market Purchase | 39,581 | $5.45 | $215,716.00 | 1% 3.56M to 3.6M | 3% |
| 25-Oct-21 4:31 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 22-Oct-21 | Market Purchase | 27,629 | $5.51 | $152,236.00 | < 1% 3.53M to 3.56M | 2% |
| 25-Oct-21 4:31 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 21-Oct-21 | Market Purchase | 32,816 | $5.40 | $177,206.00 | < 1% 3.5M to 3.53M | 4% |
| 21-Oct-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 20-Oct-21 | Market Purchase | 40,663 | $5.44 | $221,207.00 | 1% 3.46M to 3.5M | 1% |
| 21-Oct-21 4:30 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 19-Oct-21 | Market Purchase | 87,580 | $5.07 | $444,031.00 | 3% 3.37M to 3.46M | 8% |
| 19-Oct-21 5:13 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 18-Oct-21 | Market Purchase | 36,194 | $4.87 | $176,265.00 | 1% 3.33M to 3.37M | 2% |
| 19-Oct-21 5:13 PM View: | Commodore Capital Lp 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 15-Oct-21 | Market Purchase | 126,000 | $4.83 | $608,580.00 | 4% 3.21M to 3.33M | 3% |
| 05-Apr-21 4:34 PM View: | Ra Capital Management, LLC Director 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Apr-21 | Acquisition (other) | 758,398 | $5.91 | $4,482,130.00 | 15% 5.16M to 5.91M | < 1% |
| 02-Mar-21 4:30 PM View: | Ra Capital Management, LLC Director 10% Owner | Satsuma Pharmaceuticals, Inc. (STSA) | 26-Feb-21 | Market Purchase | 1,232,390 | $5.68 | $7,000,000.00 | 31% 3.92M to 5.16M | 15% |
| 03-Sep-20 4:06 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Sep-20 | Planned Option Sale | 1,000 | $22.21 | $22,210.00 | (5%) 21.21K to 20.21K | |
| 03-Sep-20 4:06 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Sep-20 | Option Exercise | 1,000 | $4.56 | $4,560.00 | 5% 20.21K to 21.21K | |
| 03-Sep-20 4:05 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Sep-20 | Option Exercise | 750 | $4.56 | $3,420.00 | 100% 0 to 0.75K | |
| 03-Sep-20 4:05 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Sep-20 | Planned Option Sale | 750 | $22.19 | $16,644.50 | (100%) 0.75K to 0 | |
| 07-Aug-20 6:40 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 05-Aug-20 | Option Exercise | 1,000 | $4.56 | $4,560.00 | 100% 0 to 1.0K | |
| 07-Aug-20 6:40 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 05-Aug-20 | Planned Option Sale | 1,000 | $25.00 | $25,000.00 | (100%) 1.0K to 0 | |
| 05-Aug-20 4:03 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 03-Aug-20 | Option Exercise | 1,000 | $4.56 | $4,560.00 | 5% 20.21K to 21.21K | |
| 05-Aug-20 4:03 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 03-Aug-20 | Planned Option Sale | 1,000 | $22.91 | $22,905.60 | (5%) 21.21K to 20.21K | |
| 02-Jul-20 4:15 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jul-20 | Planned Option Sale | 1,000 | $26.65 | $26,653.90 | (100%) 1.0K to 0 | |
| 02-Jul-20 4:13 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jul-20 | Planned Option Sale | 1,000 | $26.68 | $26,683.10 | (5%) 21.21K to 20.21K | |
| 02-Jul-20 4:13 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jul-20 | Option Exercise | 1,000 | $4.56 | $4,560.00 | 5% 20.21K to 21.21K | |
| 02-Jul-20 4:15 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jul-20 | Option Exercise | 1,000 | $4.56 | $4,560.00 | 100% 0 to 1.0K | |
| 24-Jun-20 4:53 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 23-Jun-20 | Option Exercise | 2,115 | $1.04 | $2,199.60 | 100% 0 to 2.12K | |
| 24-Jun-20 4:53 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 23-Jun-20 | Planned Option Sale | 2,115 | $35.23 | $74,511.90 | (100%) 2.12K to 0 | |
| 02-Jun-20 7:33 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jun-20 | Planned Option Sale | 1,000 | $25.26 | $25,256.90 | (5%) 21.21K to 20.21K | |
| 02-Jun-20 7:31 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jun-20 | Option Exercise | 1,000 | $4.56 | $4,560.00 | 100% 0 to 1.0K | |
| 02-Jun-20 7:33 PM View: | Albrecht Detlef Chief Medical Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jun-20 | Option Exercise | 1,000 | $4.56 | $4,560.00 | 5% 20.21K to 21.21K | |
| 02-Jun-20 7:31 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 01-Jun-20 | Planned Option Sale | 1,000 | $25.32 | $25,323.50 | (100%) 1.0K to 0 | |
| 21-May-20 5:34 PM View: | O'Neil Thomas P. Chief Financial Officer | Satsuma Pharmaceuticals, Inc. (STSA) | 20-May-20 | Planned Option Sale | 2,000 | $25.00 | $50,000.00 | (100%) 2.0K to 0 |
